
Results
5
Mid-Large Cap Stocks
5 companies
Almirall
Market Cap: €2.4b
Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.
ALM
€11.38
7D
2.7%
1Y
4.0%
Grifols
Market Cap: €5.6b
Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.
GRF
€9.09
7D
1.3%
1Y
-14.5%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€58.45
7D
-0.4%
1Y
4.1%
Faes Farma
Market Cap: €1.4b
Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally.
FAE
€4.52
7D
-0.2%
1Y
1.0%
Pharma Mar
Market Cap: €1.2b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€68.30
7D
-19.5%
1Y
-16.2%